Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rayyan Hemetsberger

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
JACC. Cardiovascular Interventions|September 22, 2022
Rotational Atherectomy or Balloon-Based Techniques to Prepare Severely Calcified Coronary LesionsTobias Rheude, Sean Fitzgerald, Abdelhakim Allali, et al.
Journal of the American Heart Association|December 14, 2022
Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes - A Post-hoc Analysis of the ISAR-REACT 5 TrialShqipdona Lahu, Maria Scalamogna, Gjin Ndrepepa, et al.
Thrombosis and Haemostasis|November 28, 2022
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesTobias Koch, Shqipdona Lahu, J J Coughlan, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 22, 2022
Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes-a subgroup analysis of the ISAR-REACT 5 trialShqipdona Lahu, Gjin Ndrepepa, Franz-Josef Neumann, et al.
Circulation. Cardiovascular Interventions|October 18, 2022
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding RiskShqipdona Lahu, Antonia Presch, Gjin Ndrepepa, et al.
Nature Clinical Practice. Cardiovascular Medicine|November 13, 2008
Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized studyMariann Gyöngyösi, Irene Lang, Markus Dettke, et al.
JACC. Cardiovascular Interventions|August 27, 2021
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration RateJochen Wöhrle, Julia Seeger, Shqipdona Lahu, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 20, 2022
Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment StrategyRayyan Hemetsberger, Gert Richardt, Shqipdona Lahu, et al.
The Canadian Journal of Cardiology|December 26, 2023
In-hospital Outcomes of Rotational Atherectomy in ST-Elevation Myocardial Infarction: Results From the Multicentre ROTA-STEMI NetworkRayyan Hemetsberger, Nader Mankerious, Guillem Muntané-Carol, et al.
Frontiers in Bioengineering and Biotechnology|April 20, 2018
Matrix Metalloproteinase-2 Impairs Homing of Intracoronary Delivered Mesenchymal Stem Cells in a Porcine Reperfused Myocardial Infarction: Comparison With Intramyocardial Cell DeliveryKatrin Zlabinger, Dominika Lukovic, Rayyan Hemetsberger, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
JACC. Cardiovascular Interventions|September 22, 2022
Rotational Atherectomy or Balloon-Based Techniques to Prepare Severely Calcified Coronary LesionsTobias Rheude, Sean Fitzgerald, Abdelhakim Allali, et al.
Journal of the American Heart Association|December 14, 2022
Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes - A Post-hoc Analysis of the ISAR-REACT 5 TrialShqipdona Lahu, Maria Scalamogna, Gjin Ndrepepa, et al.
Thrombosis and Haemostasis|November 28, 2022
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesTobias Koch, Shqipdona Lahu, J J Coughlan, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 22, 2022
Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes-a subgroup analysis of the ISAR-REACT 5 trialShqipdona Lahu, Gjin Ndrepepa, Franz-Josef Neumann, et al.
Circulation. Cardiovascular Interventions|October 18, 2022
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding RiskShqipdona Lahu, Antonia Presch, Gjin Ndrepepa, et al.
Nature Clinical Practice. Cardiovascular Medicine|November 13, 2008
Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized studyMariann Gyöngyösi, Irene Lang, Markus Dettke, et al.
JACC. Cardiovascular Interventions|August 27, 2021
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration RateJochen Wöhrle, Julia Seeger, Shqipdona Lahu, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 20, 2022
Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment StrategyRayyan Hemetsberger, Gert Richardt, Shqipdona Lahu, et al.
The Canadian Journal of Cardiology|December 26, 2023
In-hospital Outcomes of Rotational Atherectomy in ST-Elevation Myocardial Infarction: Results From the Multicentre ROTA-STEMI NetworkRayyan Hemetsberger, Nader Mankerious, Guillem Muntané-Carol, et al.
Frontiers in Bioengineering and Biotechnology|April 20, 2018
Matrix Metalloproteinase-2 Impairs Homing of Intracoronary Delivered Mesenchymal Stem Cells in a Porcine Reperfused Myocardial Infarction: Comparison With Intramyocardial Cell DeliveryKatrin Zlabinger, Dominika Lukovic, Rayyan Hemetsberger, et al.
Pageof 8